Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study

Diagnosis and Evaluation of Hypertrophic Cardiomyopathy

(2022) Barry J. Maron et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Left atrial reservoir strain improves diagnostic accuracy of the 2016 ASE/EACVI diastolic algorithm in patients with preserved left ventricular ejection fraction: insights from the KARUM haemodynamic database

(2022) Ashwin Venkateshvaran et al.   European Heart Journal-Cardiovascular Imaging

Left Atrial Reservoir Strain-Based Left Ventricular Diastolic Function Grading and Incident Heart Failure in Hypertrophic Cardiomyopathy

(2022) Hyun-Jung Lee et al.   Circulation-Cardiovascular Imaging

Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic Cardiomyopathy

(2022) Michael Nassif et al.   JACC-Heart Failure

Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy

(2022) Milind Y. Desai et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy

(2021) Milind Y. Desai et al.   AMERICAN HEART JOURNAL

Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

(2021) Sheila M. Hegde et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Multimodality Imaging in Hypertrophic Cardiomyopathy for Risk Stratification

(2020) Albree Tower-Rader et al.   Circulation-Cardiovascular Imaging

Imaging of Diastolic Dysfunction in Community-Based Epidemiological Studies and Randomized Controlled Trials of HFpEF

(2020) Michael Chetrit et al.   JACC-Cardiovascular Imaging

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

(2020) Iacopo Olivotto et al.   LANCET

Prognostic significance of left ventricular end diastolic pressure using E/E' in patients with hypertrophic cardiomyopathy

(2019) Hala Mahfouz Badran et al.   ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES

Clinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic Cardiomyopathy

(2018) Sophie Wells et al.   AMERICAN JOURNAL OF MEDICINE

E/eʹ ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy

(2018) Juan Pablo Costabel et al.   ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES

Clinical Spectrum and Management of Heart Failure in Hypertrophic Cardiomyopathy

(2018) Barry J. Maron et al.   JACC-Heart Failure

Clinical Course and Management of Hypertrophic Cardiomyopathy

(2018) Barry J. Maron   NEW ENGLAND JOURNAL OF MEDICINE

Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation

(2017) William A. Zoghbi et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2016) Sherif F. Nagueh et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice

(2016) E. M. Green et al.   SCIENCE

Advanced Heart Failure With Preserved Systolic Function in Nonobstructive Hypertrophic Cardiomyopathy

(2014) Ethan J. Rowin et al.   Circulation-Heart Failure

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary

(2011) et al.   CIRCULATION